Basics |
BioXcel Therapeutics, Inc.
|
IPO Date: |
March 5, 2018 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$9.51M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.64 | 4.11%
|
Avg Daily Range (30 D): |
$0.09 | 4.98%
|
Avg Daily Range (90 D): |
$0.11 | 7.17%
|
Institutional Daily Volume |
Avg Daily Volume: |
.68M |
Avg Daily Volume (30 D): |
.24M |
Avg Daily Volume (90 D): |
3.19M |
Trade Size |
Avg Trade Size (Sh.): |
128 |
Avg Trade Size (Sh.) (30 D): |
240 |
Avg Trade Size (Sh.) (90 D): |
266 |
Institutional Trades |
Total Inst.Trades: |
897 |
Avg Inst. Trade: |
$1.45M |
Avg Inst. Trade (30 D): |
$.6M |
Avg Inst. Trade (90 D): |
$.6M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.56M |
Avg Closing Trade (30 D): |
$2.34M |
Avg Closing Trade (90 D): |
$2.34M |
Avg Closing Volume: |
3.96K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-23.51
|
$-22.22
|
$-23.51
|
Diluted EPS
|
$-23.51
|
$-22.22
|
$-23.51
|
Revenue
|
$ 2.27M
|
$ .37M
|
$ 2.27M
|
Gross Profit
|
$ .12M
|
$ -.47M
|
$ .12M
|
Net Income / Loss
|
$ -59.6M
|
$ -10.86M
|
$ -59.6M
|
Operating Income / Loss
|
$ -67.25M
|
$ -10.49M
|
$ -67.25M
|
Cost of Revenue
|
$ 2.14M
|
$ .83M
|
$ 2.14M
|
Net Cash Flow
|
$ M
|
$ M
|
$ M
|
PE Ratio
|
|
|
|
Splits |
Feb 10, 2025:
16:1
|
|